AFM: Afamin
A vitamin E-binding glycoprotein with roles in fertility, neuroprotection, and metabolic regulation
Gene Information Card
| Symbol | AFM |
|---|---|
| Full Name | Afamin |
| Gene Type | Protein coding |
| Chromosomal Location | 4q13.3 |
| NCBI Gene ID | 173 ncbi.nlm.nih.gov/gene/173 |
| Ensembl ID | ENSG00000138684 |
| UniProt ID | P43652 |
| OMIM ID | 104150 |
| HGNC ID | 316 |
| Aliases | ALB2, ALBA, ALF |
Description
The AFM gene encodes afamin, a member of the albumin gene family. Afamin is a glycoprotein primarily synthesized in the liver and secreted into the bloodstream. It functions as a vitamin E-binding protein, facilitating the transport of alpha-tocopherol and protecting cells from oxidative stress. Afamin is also implicated in fertility, neuroprotection, and metabolic regulation. Its expression is modulated in various physiological and pathological states, including ovarian hyperstimulation syndrome, preeclampsia, and certain cancers.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Ovarian hyperstimulation syndrome | Elevated afamin levels in follicular fluid may contribute to increased vascular permeability and fluid shift | ClinVar, NCBI |
| Preeclampsia | Altered afamin expression in maternal serum is associated with oxidative stress and endothelial dysfunction | NCBI, OMIM |
| Infertility | Afamin levels in follicular fluid correlate with oocyte quality and IVF outcomes | NCBI |
| Neurodegenerative disorders | Afamin's vitamin E-binding capacity may protect neurons from oxidative damage | UniProt, NCBI |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Liver | 45.2 | High |
| Kidney | 8.1 | Medium |
| Testis | 6.3 | Medium |
| Ovary | 5.0 | Low |
| Brain | 2.4 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HepG2 | 32.5 | Hepatocellular carcinoma cell line; high expression |
| HEK293 | 12.1 | Embryonic kidney cells; moderate expression |
| K562 | 3.8 | Leukemia cell line; low expression |
| MCF7 | 2.1 | Breast cancer cell line; low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1A>G | SNV | <0.01% | Start codon loss; predicted loss of function |
| p.Arg240Cys | Missense | <0.01% | Alters disulfide bond; potential impact on protein stability |
| p.Val370Met | Missense | <0.01% | Located in albumin domain; functional significance unknown |
Mutation functional classification
Loss of Function (LOF)
Rare start-loss and missense variants may reduce afamin secretion or vitamin E binding capacity.
Gain of Function (GOF)
No gain-of-function mutations reported.
Dominant Negative (DN)
No dominant-negative mutations reported.
View complete mutation data:
Gene Ontology (GO)
| • GO:0005504 - fatty acid binding | • GO:0008439 - vitamin E binding |
| • GO:0005615 - extracellular space | • GO:0031418 - L-ascorbic acid binding |
| • GO:0042310 - negative regulation of oxidative stress-induced cell death |
Pathways
• Vitamin E transport and metabolism
• Oxidative stress response
• Albumin family protein interactions
Protein Summary
Afamin is a 87 kDa glycoprotein composed of 578 amino acids. It contains three albumin-like domains and binds vitamin E (alpha-tocopherol) with high affinity. The protein is secreted into plasma and other body fluids, including follicular fluid, cerebrospinal fluid, and amniotic fluid. Afamin protects cells from oxidative stress by delivering vitamin E to tissues. It also interacts with fatty acids and ascorbic acid. Post-translational modifications include N-glycosylation at Asn-45 and Asn-307, which are critical for stability and function.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| AFM Knockout HEK293 Cell Line | EDJ-KQ4024 | Human | 173 | Details Get a Quote |
| AFMID Knockout HEK293 Cell Line | EDJ-KQ8718 | Human | 125061 | Details Get a Quote |
| INAFM1 Knockout HEK293 Cell Line | EDJ-KQ11808 | Human | 255783 | Details Get a Quote |
| INAFM2 Knockout HEK293 Cell Line | EDJ-KQ13834 | Human | 100505573 | Details Get a Quote |
| AFMID Knockout A-549 Cell Line | EDJ-KQ34944 | Human | 125061 | Details Get a Quote |
| AFMID Knockout HCT 116 Cell Line | EDJ-KQ34945 | Human | 125061 | Details Get a Quote |
| AFMID Knockout HeLa Cell Line | EDJ-KQ34946 | Human | 125061 | Details Get a Quote |
| INAFM1 Knockout A-549 Cell Line | EDJ-KQ40224 | Human | 255783 | Details Get a Quote |
| INAFM1 Knockout HCT 116 Cell Line | EDJ-KQ40225 | Human | 255783 | Details Get a Quote |
| INAFM1 Knockout HeLa Cell Line | EDJ-KQ40226 | Human | 255783 | Details Get a Quote |
| INAFM2 Knockout A-549 Cell Line | EDJ-KQ42391 | Human | 100505573 | Details Get a Quote |
| INAFM2 Knockout HCT 116 Cell Line | EDJ-KQ43663 | Human | 100505573 | Details Get a Quote |
| INAFM2 Knockout HeLa Cell Line | EDJ-KQ43664 | Human | 100505573 | Details Get a Quote |
| AFM Knockout HeLa Cell Line | EDJ-KQ52577 | Human | 173 | Details Get a Quote |
| AFM Knockout A-549 Cell Line | EDJ-KQ61055 | Human | 173 | Details Get a Quote |
Displaying Records 1 To 15 Of 16 Records